Uncategorized

UK signs off on US pharma deal, ensuring tariff reprieve as Britain aims to reattract investments

Published

5 days ago

on

The U.K.’s end of the deal requires it to spend more on drugs through its National Health Service, which it is implementing through a higher cost-effectiveness threshold for its National Institute for Health and Care Excellence (NICE).

Related Topics:

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending

Exit mobile version